14.68
price up icon0.89%   0.115
 
loading
Schlusskurs vom Vortag:
$14.56
Offen:
$14.63
24-Stunden-Volumen:
257.06K
Relative Volume:
0.34
Marktkapitalisierung:
$576.81M
Einnahmen:
$128.29M
Nettoeinkommen (Verlust:
$-30.69M
KGV:
-17.90
EPS:
-0.82
Netto-Cashflow:
$-27.17M
1W Leistung:
+2.58%
1M Leistung:
-44.69%
6M Leistung:
-71.84%
1J Leistung:
-72.42%
1-Tages-Spanne:
Value
$14.43
$14.89
1-Wochen-Bereich:
Value
$14.30
$15.18
52-Wochen-Spanne:
Value
$13.50
$66.54

Rxsight Inc Stock (RXST) Company Profile

Name
Firmenname
Rxsight Inc
Name
Telefon
949-521-7822
Name
Adresse
100 COLUMBIA STREET, ALISO VIEJO
Name
Mitarbeiter
498
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
RXST's Discussions on Twitter

Vergleichen Sie RXST mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Medical Devices icon
RXST
Rxsight Inc
14.69 576.81M 128.29M -30.69M -27.17M -0.82
Medical Devices icon
ABT
Abbott Laboratories
130.33 225.27B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
102.34 138.41B 17.55B 2.03B 2.37B 1.37
Medical Devices icon
SYK
Stryker Corp
368.82 129.62B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
84.73 107.76B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
75.73 40.53B 5.54B 4.18B 259.90M 7.00

Rxsight Inc Stock (RXST) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-15 Eingeleitet Piper Sandler Neutral
2025-04-09 Herabstufung UBS Buy → Neutral
2025-04-04 Herabstufung JP Morgan Overweight → Underweight
2025-04-03 Herabstufung BofA Securities Buy → Underperform
2024-12-20 Herabstufung Stifel Buy → Hold
2024-12-11 Herabstufung Wells Fargo Overweight → Equal Weight
2024-12-06 Eingeleitet UBS Buy
2024-10-29 Eingeleitet Jefferies Buy
2024-08-20 Bestätigt Needham Buy
2024-08-06 Bestätigt Needham Buy
2024-05-07 Bestätigt BTIG Research Buy
2023-12-13 Hochstufung Wells Fargo Equal Weight → Overweight
2023-12-12 Eingeleitet Stifel Buy
2023-12-04 Eingeleitet Morgan Stanley Overweight
2023-04-13 Eingeleitet Oppenheimer Outperform
2022-12-12 Herabstufung Wells Fargo Overweight → Equal Weight
2022-04-08 Eingeleitet Needham Buy
Alle ansehen

Rxsight Inc Aktie (RXST) Neueste Nachrichten

pulisher
Apr 27, 2025

Russell Investments Group Ltd. Sells 94,412 Shares of RxSight, Inc. (NASDAQ:RXST) - Defense World

Apr 27, 2025
pulisher
Apr 27, 2025

JPMorgan Chase & Co. Reduces Stake in RxSight, Inc. (NASDAQ:RXST) - Defense World

Apr 27, 2025
pulisher
Apr 26, 2025

RxSight, Inc. (NASDAQ:RXST) Given Average Recommendation of “Hold” by Brokerages - Defense World

Apr 26, 2025
pulisher
Apr 25, 2025

RxSight Inc [RXST] Records 50-Day SMA of $23.43 - knoxdaily.com

Apr 25, 2025
pulisher
Apr 25, 2025

What Does RxSight, Inc.'s (NASDAQ:RXST) Share Price Indicate? - Yahoo Finance

Apr 25, 2025
pulisher
Apr 23, 2025

RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025 - The Manila Times

Apr 23, 2025
pulisher
Apr 23, 2025

RxSight, Leading Eye Surgery Tech Company, Sets Q1 2025 Earnings Release Date - Stock Titan

Apr 23, 2025
pulisher
Apr 22, 2025

LPL Financial LLC Boosts Holdings in RxSight, Inc. (NASDAQ:RXST) - Defense World

Apr 22, 2025
pulisher
Apr 18, 2025

Geode Capital Management LLC Has $28.57 Million Stock Position in RxSight, Inc. (NASDAQ:RXST) - Defense World

Apr 18, 2025
pulisher
Apr 15, 2025

Piper Sandler Initiates Coverage of RxSight (RXST) with Neutral Recommendation - Nasdaq

Apr 15, 2025
pulisher
Apr 15, 2025

This Aurora Innovation Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday - Benzinga

Apr 15, 2025
pulisher
Apr 15, 2025

Piper Sandler Initiates RxSight at Neutral With $18 Price Target - marketscreener.com

Apr 15, 2025
pulisher
Apr 15, 2025

Piper Sandler Begins Coverage of RxSight (RXST) with Neutral Rat - GuruFocus

Apr 15, 2025
pulisher
Apr 15, 2025

Piper Sandler sets RxSight stock target at $18, stays neutral By Investing.com - Investing.com South Africa

Apr 15, 2025
pulisher
Apr 15, 2025

Piper Sandler sets RxSight stock target at $18, stays neutral - Investing.com

Apr 15, 2025
pulisher
Apr 15, 2025

Piper Sandler Starts RxSight Inc. (RXST) at Neutral - StreetInsider

Apr 15, 2025
pulisher
Apr 13, 2025

RxSight price target lowered to $17 from $22 at Wells Fargo - MSN

Apr 13, 2025
pulisher
Apr 11, 2025

RxSight plunges after guidance cut; BofA downgrades - MSN

Apr 11, 2025
pulisher
Apr 10, 2025

RxSight stock plunges to 52-week low at $14.24 amid market challenges By Investing.com - Investing.com South Africa

Apr 10, 2025
pulisher
Apr 10, 2025

RxSight stock plunges to 52-week low at $14.24 amid market challenges - Investing.com

Apr 10, 2025
pulisher
Apr 10, 2025

RxSight, Inc. (NASDAQ:RXST) Position Lifted by Vanguard Group Inc. - The AM Reporter

Apr 10, 2025
pulisher
Apr 09, 2025

UBS cuts RxSight stock rating to neutral, slashes price target to $16 By Investing.com - Investing.com South Africa

Apr 09, 2025
pulisher
Apr 09, 2025

RxSight downgraded at UBS after Q1 miss and guidance cut - MSN

Apr 09, 2025
pulisher
Apr 09, 2025

RxSight stock downgraded at UBS on guidance cut (RXST:NASDAQ) - Seeking Alpha

Apr 09, 2025
pulisher
Apr 09, 2025

Needham Cuts Price Target on RxSight to $22 From $43, Keeps Buy Rating - MarketScreener

Apr 09, 2025
pulisher
Apr 09, 2025

UBS Downgrades RxSight to Neutral From Buy, Cuts Price Target to $16 From $45 - MarketScreener

Apr 09, 2025
pulisher
Apr 09, 2025

UBS cuts RxSight stock rating to neutral, slashes price target to $16 - Investing.com Australia

Apr 09, 2025
pulisher
Apr 09, 2025

UBS Downgrades RxSight Inc. (RXST) to Neutral - StreetInsider

Apr 09, 2025
pulisher
Apr 08, 2025

RxSight at Needham Conference: Strategic Adjustments Amid Market Challenges By Investing.com - Investing.com Canada

Apr 08, 2025
pulisher
Apr 07, 2025

Analysts Are Neutral on Top Healthcare Stocks: RxSight (RXST), Johnson & Johnson (JNJ) - The Globe and Mail

Apr 07, 2025
pulisher
Apr 05, 2025

Needham & Company LLC Reiterates “Buy” Rating for RxSight (NASDAQ:RXST) - Defense World

Apr 05, 2025
pulisher
Apr 05, 2025

Rxsight adjusts 2025 revenue guidance to $160M-$175M amid premium IOL market challenges - MSN

Apr 05, 2025
pulisher
Apr 04, 2025

Midday Stock Roundup: Masimo, Virgin Galactic an Others Take Dives - Orange County Business Journal

Apr 04, 2025
pulisher
Apr 04, 2025

JP Morgan downgrades RxSight on market, competitive pressures - Investing.com

Apr 04, 2025
pulisher
Apr 04, 2025

JPMorgan Downgrades RxSight to Underweight From Overweight, Adjusts Price Target to $17 From $40 - MarketScreener

Apr 04, 2025
pulisher
Apr 04, 2025

Deep Dive Into RxSight Stock: Analyst Perspectives (12 Ratings) - Benzinga

Apr 04, 2025
pulisher
Apr 04, 2025

RxSight’s preliminary Q1 2025 revenue expected to increase 28% - Medical Buyer

Apr 04, 2025
pulisher
Apr 04, 2025

American Express, Rxsight, Vertiv Holdings - TradingView

Apr 04, 2025
pulisher
Apr 04, 2025

RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Strong Year-Over-Year Growth Amid Revised ... By GuruFocus - Investing.com Canada

Apr 04, 2025
pulisher
Apr 04, 2025

JPMorgan Double Downgrades RxSight Inc. (RXST) to Underweight - StreetInsider

Apr 04, 2025
pulisher
Apr 04, 2025

RxSight Faces Market Challenges As Revenue Guidance Drops - Finimize

Apr 04, 2025
pulisher
Apr 03, 2025

​RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade) - Seeking Alpha

Apr 03, 2025
pulisher
Apr 03, 2025

JPMorgan cuts RxSight stock rating, slashes price target to $17 By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

JPMorgan cuts RxSight stock rating, slashes price target to $17 - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight stock plunges to 52-week low at $15.84 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight stock plunges to 52-week low at $15.84 amid market challenges - Investing.com India

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight downgraded to Underweight from Overweight at JPMorgan - TipRanks

Apr 03, 2025
pulisher
Apr 03, 2025

Earnings call transcript: RxSight Q1 2025 sees revenue growth, stock dips By Investing.com - Investing.com South Africa

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight Analyst Flags Growth Slowdown As Revised Outlook Misses Expectations - Benzinga

Apr 03, 2025
pulisher
Apr 03, 2025

Biotech Shake-Up: Aldeyra Therapeutics & Others Feel The Heat - Finimize

Apr 03, 2025
pulisher
Apr 03, 2025

RxSight plunges after guidance cut - MSN

Apr 03, 2025

Finanzdaten der Rxsight Inc-Aktie (RXST)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Rxsight Inc-Aktie (RXST) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Fountain Tamara
Director
Mar 12 '25
Sale
25.71
7,000
180,002
24,793
medical_devices ZBH
$101.56
price down icon 0.45%
medical_devices STE
$224.03
price down icon 0.68%
medical_devices PHG
$25.12
price down icon 0.44%
$68.07
price up icon 0.28%
$71.31
price down icon 0.24%
medical_devices EW
$75.19
price up icon 0.07%
Kapitalisierung:     |  Volumen (24h):